Muğlu, H., Sünger, E., Özkan, O., Şahin, T. K., Köylü, B., Helvacı, K., Kemal, Y., Demirci, U., Selçukbiricik, F., Başaran, G., Uluç, B. O., Olmez, O. F., Aksoy, S., Gökmen, E., Bilici, A. (2026). Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study. Scientific Reports. https://doi.org/10.1038/s41598-026-47351-7